At its 62nd session in March 2019 the Commission on Narcotic Drugs (CND) adopted by consensus the Ministerial Declaration entitled “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of our Joint Commitments to Address and Counter the World Drug Problem”. (https://www.unodc.org/documents/commissions/CND/2019/Ministerial_Declaration.pdf)

Following the format used for the thematic discussions held within the CND since 2016, Member States developed a multi-year workplan and will hold, every autumn, inter-active meetings aiming to address...

Mexico's National Institute of Psychiatry, "Ramón de la Fuente Muñiz" began editing its official publication in 1977, "Salud Mental", which is currently indexed in: WoS, ScopuS, Academic Search Premier, SciELO, PsycINFO, IMBIOMED, RedALyC, LILACS, DIALNET, Latindex, and the Sistema de Clasificación de Revistas Mexicanas de Ciencia y Tecnología (CONACyT).

Manuscripts submitted to "Salud Mental" go through a process that follows scientific publishing ethical policies. The Internal Review Board selects papers suitable for publication that must undergo a second double-blinded review by experts in...

Η κατανάλωση αλκοόλ συμβάλλει σε 3 εκατομμύρια θανάτους κάθε χρόνο παγκοσμίως, καθώς και στις αναπηρίες και την κακή υγεία εκατομμυρίων ανθρώπων. 

Η χρήση αλκοόλ μεταξύ των εφήβων μπορεί να είναι επιβλαβής για τη νευροανάπτυξη και έχει συνδεθεί με αυξημένο κίνδυνο ιδεασμού αυτοκτονίας, κατάθλιψης και επικίνδυνης σεξουαλικής συμπεριφοράς.

Στο Μεξικό, η χρήση αλκοόλ αυξάνεται σταθερά μεταξύ των νέων την τελευταία δεκαετία, προκαλώντας μια έρευνα για τη σχέση μεταξύ της αντιληπτής διαθεσιμότητας αλκοόλ, της βαριάς επεισοδιακής κατανάλωσης αλκοόλ και των βλαβών που σχετίζονται με το αλκοόλ...

The report provides a regional analysis of the key trends and emerging developments of the synthetic drugs and NPS market as well as options for response in Latin America and the Caribbean.

Over the past years, the synthetics drug market has experienced a massive expansion and diversification in the region and seen a rapid emergence of a wide range of NPS.

The latest developments include an expanding methamphetamine market, growing concerns around the non-medical use of ketamine, the emergence of fentanyl and MDMA manufacture, as well as new “ecstasy” trends such as higher dosed MDMA tablets...